Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer hid death data in COV-19 vaccine clinical trials
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(35)
•••
Comment by skyhawk1on Oct 31, 2023 10:09am
154 Views
Post# 35709064

RE:RE:RE:RE:Pfizer hid death data in COV-19 vaccine clinical trials

RE:RE:RE:RE:Pfizer hid death data in COV-19 vaccine clinical trials

What are you smoking? 93% my foot?! That's what they & the (trusted) media lol ORGINALLY said to perswayed the gullible & naive public!

Even their own internal documents when finally exposed, they REVEALED that ONLY @ 27% efficiency was the real number & they knew it.


All the top brass knew it. It was a SCAM & so many like you bought into their orchestrated BS with all the federal agencies & their political accomplices in on it. It was all about the power & money & trying to control the masses folks!!


 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities